Farallon Capital Management 13F holdings, Q2 2026
Holdings as of June 30, 2026 · filings on SEC EDGAR · this is the latest filing on record
Farallon Capital Management disclosed 86 US equity positions worth $17.1bn in its Q2 2026 13F filing. The largest position was RVMD at 14.9% of the reported book, followed by EA and BBIO. Against the Q1 2026 filing, it opened 5 new positions, added to 27 and reduced 13 among the top 50 holdings.
What did Farallon Capital Management own in Q2 2026? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2026 |
|---|---|---|---|---|---|---|---|
| 1 | RVMD REVOLUTION MEDICINES INC | Healthcare | 14.9% | $2.5bn | 13,550,796 | -0% | held |
| 2 | EA ELECTRONIC ARTS INC | Communication Services | 9.5% | $1.6bn | 7,919,500 | 6% | added |
| 3 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 4.7% | $800.1m | 10,743,063 | 15% | added |
| 4 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 4.6% | $778.2m | 6,348,906 | 0% | held |
| 5 | EXEL EXELIXIS INC | Healthcare | 4.3% | $732.8m | 13,468,010 | 3% | added |
| 6 | LQDA LIQUIDIA CORPORATION | Healthcare | 3.9% | $666.9m | 8,365,038 | -3% | reduced |
| 7 | AMZN AMAZON COM INC | Consumer Cyclical | 3.7% | $627.5m | 2,632,994 | -38% | reduced |
| 8 | LNTH LANTHEUS HLDGS INC | Healthcare | 3.6% | $619.4m | 5,583,479 | 0% | held |
| 9 | NTRA NATERA INC | Healthcare | 3.5% | $602.2m | 2,218,366 | -31% | reduced |
| 10 | UNH UNITEDHEALTH GROUP INC | Healthcare | 3.1% | $528.1m | 1,270,532 | -30% | reduced |
| 11 | TMO THERMO FISHER SCIENTIFIC INC | Healthcare | 3.1% | $526.0m | 1,049,185 | 19% | added |
| 12 | ROIV ROIVANT SCIENCES LTD | Healthcare | 3.0% | $506.4m | 14,309,000 | 48% | added |
| 13 | AON AON PLC | Financial Services | 2.7% | $458.6m | 1,382,562 | -45% | reduced |
| 14 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 2.6% | $449.0m | 10,521,184 | 41% | added |
| 15 | AVGO BROADCOM INC | Technology | 2.5% | $435.1m | 1,151,800 | -35% | reduced |
| 16 | MSFT MICROSOFT CORP | Technology | 2.4% | $415.1m | 1,112,863 | -53% | reduced |
| 17 | TNGX TANGO THERAPEUTICS INC | Healthcare | 2.2% | $383.8m | 12,277,000 | 35% | added |
| 18 | KKR KKR & CO INC | Financial Services | 2.2% | $378.0m | 4,118,300 | -12% | reduced |
| 19 | SNPS SYNOPSYS INC | Technology | 2.2% | $370.1m | 829,600 | -32% | reduced |
| 20 | BEAM BEAM THERAPEUTICS INC | Healthcare | 2.1% | $351.3m | 10,236,396 | 1% | added |
| 21 | CRINETICS PHARMACEUTICALS IN | 2.0% | $336.4m | 8,989,098 | 8% | added | |
| 22 | GRAL GRAIL INC | 1.7% | $284.1m | 4,161,584 | 28% | added | |
| 23 | WAB WABTEC | Industrials | 1.4% | $241.2m | 894,503 | -44% | reduced |
| 24 | IMVT IMMUNOVANT INC | Healthcare | 1.3% | $223.7m | 5,805,000 | 275% | added |
| 25 | TWST TWIST BIOSCIENCE CORP | Healthcare | 1.3% | $219.8m | 2,136,400 | 50% | added |
| 26 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 1.3% | $219.6m | 5,917,400 | 4% | added |
| 27 | ARMK ARAMARK | Industrials | 1.2% | $206.3m | 3,625,731 | -41% | reduced |
| 28 | BIDU BAIDU INC | Communication Services | 0.8% | $137.6m | 1,203,785 | 171% | added |
| 29 | NVO NOVO-NORDISK A S | Healthcare | 0.7% | $125.6m | 2,619,000 | 235% | added |
| 30 | ACHC ACADIA HEALTHCARE COMPANY IN | Healthcare | 0.7% | $124.6m | 4,220,800 | 143% | added |
| 31 | BTSG BRIGHTSPRING HEALTH SVCS INC | Healthcare | 0.7% | $120.8m | 1,732,800 | 7% | added |
| 32 | AZN ASTRAZENECA PLC | 0.6% | $108.8m | 574,000 | 153% | added | |
| 33 | JNJ JOHNSON & JOHNSON | Healthcare | 0.6% | $103.6m | 408,000 | 176% | added |
| 34 | STRATEGY INC | 0.4% | $75.4m | 87,858,000 | 122% | added | |
| 35 | PARABILIS MEDICINES INC | 0.4% | $64.8m | 2,368,200 | – | new | |
| 36 | NVS NOVARTIS AG | Healthcare | 0.3% | $56.9m | 363,000 | – | new |
| 37 | GH GUARDANT HEALTH INC | Healthcare | 0.3% | $48.3m | 322,200 | 3928% | added |
| 38 | VNET GROUP INC | 0.3% | $46.8m | 45,000,000 | 0% | held | |
| 39 | AVTX AVALO THERAPEUTICS INC | Healthcare | 0.3% | $46.2m | 2,498,000 | 173% | added |
| 40 | JOYY JOYY INC | Communication Services | 0.3% | $46.1m | 699,200 | 21% | added |
| 41 | ASMB ASSEMBLY BIOSCIENCES INC | Healthcare | 0.3% | $44.1m | 1,604,590 | 31% | added |
| 42 | ENTA ENANTA PHARMACEUTICALS INC | Healthcare | 0.2% | $35.3m | 2,418,202 | -16% | reduced |
| 43 | MAZE MAZE THERAPEUTICS INC | 0.2% | $33.1m | 1,107,814 | 197% | added | |
| 44 | MRK MERCK & CO INC | Healthcare | 0.1% | $25.6m | 199,000 | -45% | reduced |
| 45 | WRBY WARBY PARKER INC | Healthcare | 0.1% | $25.1m | 828,000 | – | new |
| 46 | PERCEPTIVE CAP SOLUTIONS COR | 0.1% | $24.5m | 2,250,000 | 0% | held | |
| 47 | KAILERA THERAPEUTICS INC | 0.1% | $24.2m | 1,100,000 | – | new | |
| 48 | RIO RIO TINTO PLC | Basic Materials | 0.1% | $17.4m | 183,475 | 241% | added |
| 49 | AXALTA COATING SYS LTD | 0.1% | $16.4m | 478,000 | – | new | |
| 50 | ABVX ABIVAX SA | 0.1% | $16.3m | 122,000 | 6000% | added |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.